Medinotec Inc (MDNC) Return on Equity ROE from the first quarter 2026 to first quarter 2026 and annually, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket
 


Medinotec Inc   (MDNC)

Medinotec Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Medinotec Inc in the first quarter 2026?
Medinotec Inc achieved a return on average equity (ROE) of 17.47 % in its first quarter 2026, which is below Medinotec Inc 's average return on equity, which stands at 23.52%.

ROE has advanced compared to 16.56% in the fourth quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 18 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 831, from total ROE ranking in the fourth quarter 2026 at 839.

What is ROE?




Return On Equity (May 31 2026)
I. Quarter
(Feb 28 2026)
IV. Quarter
(Nov 30 2025)
III. Quarter
(Aug 31 2025)
II. Quarter
(May 31 2025)
I. Quarter
Y / Y Equity Change 33.96 % 33.73 % 97.07 % 91.22 % -
Y / Y Net Income Change 95.12 % - 30 % 21.71 % 30.48 %
Net Income (TTM) in Millions 1 1 2 2 2
Return On Equity (TTM) 17.47 % 16.56 % 52.76 % 57.47 % 65.57 %
MDNC's Total Ranking # 831 # 839 # 5 # 39 # 96
Equity (TTM) in Millions 6 6 4 5 4
Seq. Equity Change 2.47 % 33.73 % -11.71 % 10.72 % 2.29 %
Seq. Net Income Change - - 16.4 % 204.58 % -92.3 %

Return On Equity Company Ranking
Within: No.
Industry # 19
Sector # 93
Overall # 831

Return On Equity Statistics
High Average Low
77 %
23.52 %
-23.5 %
(Feb 28 2025)   (Feb 29 2024)





MDNC Annual Return On Equity (Feb 28 2026)
2026
(Feb 28 2025)
2025
(Feb 29 2024)
2024
(Feb 28 2023)
2023

Total Equity in Millions 6 4 2 0 0
Y / Y Equity Change 33.73 % 97.07 % - - -
Net Income in Millions 1 2 0 0 0
Y / Y Net Income Change -63.21 % - - - -
Return On Equity 13.91 % 50.56 % -18.67 % - -





Annual Roe Comment
In 2026 ROE decreased compared to the previous year to 13.91 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDNC's' Return on Equity at Yahoo Finance
MDNC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDNC's Competitors
Subscribers only: Roe for Medinotec Inc 's Suppliers
Subscribers only: Return On Equity for MDNC's Customers




Companies with similar Return On Equity at May 31 2026, within Healthcare Sector ROE
Bristol myers Squibb Company  46.65 %
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %


Date modified: 2026-07-10T05:52:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.